Incidentally found adrenocortical carcinoma. A study of 21 patients

European Journal of Cancer

Volumn 34, Issue 11, 1998, Pages 1721-1724

  Kasperlik Zaluska A A ^a   Migdalska, B M ^a   Makowska, A M ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Adrenocortical carcinoma; Computed tomography; Corticosteroids; Incidentally found adrenal tumour; Mitotane; Tumour size; Ultrasound scan

Indexed keywords

CISPLATIN; COBALT 60; CORTICOSTEROID; MITOTANE;

ADOLESCENT; ADRENAL CORTEX CARCINOMA; ADRENAL TUMOR; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COBALT THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID RELEASE; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STEROIDOGENESIS; TUMOR VOLUME;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MITOTANE; STEROIDS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0032189812     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00170-1     Document Type: Article

References (25)

1. 1. Kasperlik-Załuska AA, Rosłonowska E, Słowińska-Srzednicka J, et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol 1997, 46, 29-37.
2. 2. Kasperlik-Załuska AA, Tołłoczko T, Abuzeid IA, et al. Incidentally found adrenal tumours (observation of 310 cases). Endokrynol Pol 1997, 48(Suppl. 2), 14.
3. 3. Hart MM, Straw JA. Studies on the site of action of o,p′-DDD in the dog adrenal cortex. 1. Inhibition of ACTH-mediated pregnenolone synthesis. Steroids 1971, 17, 559-574.
4. 4. Hart MM, Swackhammer ES, Straw JA. Studies on the site of action of o,p′-DDD in the dog adrenal cortex. II. TPNH - and corticosteroid precursor-stimulation of o,p′-DDD inhibited steroidogenesis. Steroids 1971, 17, 575-586.
5. 5. Hogan TF, Citrin DL, Johnson BM, Nakmura S, Davis TE, Borden EC. o,p′-DDD (Mitotane) therapy of adrenal cortical carcinoma. Cancer 1978, 42, 2177-2181.
6. 6. Kasperlik-Załuska AA, Migdalska BM, Zgliczyński S, Makowska AM. Adrenocortical carcinoma: a clinical study and treatment results of 52 patients. Cancer 1995, 75, 2587-2591.
7. 7. Hough AJ, Hollifield JW, Page DL, Hartmann WH. Prognostic factors in adrenal cortical tumors: a mathematical analysis of clinical and morphologic data. Am J Clin Pathol 1979, 72, 390-399.
8. 8. Summary Staging Guide for Cancer Surveillance, Epidemiology and End Result Reporting Program: April 1977. Bethesda, MD, Department of Health, Education and Welfare, Public Health Service, National Institutes of Health, 1977, 12-14.
9. 9. Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA. Adrenal cortical carcinoma. Cancer 1989, 64, 765-769.
10. 10. Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. New Engl J Med 1990, 322, 1195-1201.
11. 11. Vassilopoulou-Sellin R, Guinee VF, Klein MJ, et al. Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. Cancer 1993, 71, 3119-3123.
12. 12. Bukowski RM, Wolfe M, Levine HS, et al. Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study. J Clin Oncol 1993, 11, 161-165.
13. 13. Wooten MD, King DK. Adrenal cortical carcinoma: epidemiology and treatment with mitotane and a review of the literature. Cancer 1993, 72, 3145-3155.
14. 14. Haak HR, Hermans J, Velde CJH van de, et al. Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 1994, 69, 947-951.
15. 15. Kasperlik-Załuska AA, Migdalska B, Jeske W, et al. Incidentally found adrenal tumours: results of investigation of the pituitary-adrenal axis. Endokrynol Pol 1992, 43, 322-329.
16. 16. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocrine Rev 1995, 16, 460-484.
17. 17. Dobbie JW. Adrenocortical nodular hyperplasia: the ageing adrenal. J Pathol 1969, 99, 1-18.
18. 18. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 1992, 75, 826-832.
19. 19. Griffing GT. Editorial: A-I-D-S: the new endocrine epidemic. J Clin Endocrinol Metab 1994, 79, 1530-1531.
20. 20. Osella G, Terzolo M, Borretta G, et al. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J Clin Endocrinol Metab 1994, 79, 1532-1539.
21. 21. Ambrosi B, Peverelli S, Passini E, et al. Abnormalities of endocrine function in patients with clinically "silent" adrenal masses. Eur J Endocrinol 1995, 132, 422-428.
22. 22. Oelkers W. Diagnostic puzzle of the adrenal "incidentaloma". Eur J Endocrinol 1995, 132, 419-421.
23. 23. Bencsik Z, Szabolcs I, Góth M, et al. Incidentally detected adrenal tumours (incidentalomas): histological heterogeneity and differentiated therapeutic approach. J Int Med 1995, 237, 585-589.
24. 24. Hopkins KD. Size of adrenal masses does not predict malignancy. Lancet 1997, 349, 478.
25. 25. Reznek RH, Armstrong P. The adrenal gland. Clin Endocrinol 1994, 40, 561-576.